Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus

Journal of Immunological Methods

Volumn 352, Issue 1-2, 2010, Pages 147-152

  Hanly, John G ^a   Thompson, Kara ^a   McCurdy, Grace ^a   Fougere, Lisa ^a   Theriault, Chris ^a   Wilton, Kathleen ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Autoantibodies; Laboratory techniques; Lupus

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBODY; ANTIMALARIAL AGENT; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CENTROMERE ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; IMMUNOSUPPRESSIVE AGENT; JO 1 ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RIBOSOMAL ANTIBODY; SLC 70 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CHROMATIN; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOMAGNETIC SEPARATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NEPHRITIS; PROGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 71849102119     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2009.10.003     Document Type: Article

References (25)

1. Al Attia H.M., and D'Souza M.S. Antitopoisomerase I antibody in patients with systemic lupus erythematosus/sicca syndrome without a concomitant scleroderma: two case reports. Clin. Rheumatol. 22 (2003) 70
2. Bardin N., Desplat-Jego S., Daniel L., Jourde Chiche N., and Sanmarco M. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus. Autoimmunity 42 (2009) 63
3. Binder S.R. Autoantibody detection using multiplex technologies. Lupus 15 (2006) 412
4. Binder S.R., Genovese M.C., Merrill J.T., Morris R.I., and Metzger A.L. Computer-assisted pattern recognition of autoantibody results. Clin. Diagn. Lab. Immunol. 12 (2005) 1353
5. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., and Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35 (1992) 630
6. Chuan M.T., Wu Y.C., Ang E.T., Wang J.H., In K.L., and Lu Y.C. Clinical significance of anti-nDNA antibodies in ANA-positive systemic lupus erythematosus: comparison of the Farr radioimmunoassay and the Crithidia luciliae immunofluorescent technique. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 18 (1985) 15
7. Desplat-Jego S., Bardin N., Larida B., and Sanmarco M. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods. Ann. N. Y. Acad. Sci. 1109 (2007) 245
8. Fritzler M.J. Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 15 (2006) 422
9. Fritzler M.J., and Fritzler M.L. The emergence of multiplexed technologies as diagnostic platforms in systemic autoimmune diseases. Curr. Med. Chem. 13 (2006) 2503
10. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., Bacon P., Bombardieri S., Hanly J., Hay E., Isenberg D., Jones J., Kalunian K., Maddison P., Nived O., Petri M., Richter M., Sanchez-Guerrero J., Snaith M., Sturfelt G., Symmons D., and Zoma A. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 39 (1996) 363
11. Gussin H.A., Ignat G.P., Varga J., and Teodorescu M. Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 44 (2001) 376
12. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40 (1997) 1725
13. Hoehler F.K. Bias and prevalence effects on kappa viewed in terms of sensitivity and specificity. J. Clin. Epidemiol. 53 (2000) 499
14. Kavanaugh A. The utility of immunologic laboratory tests in patients with rheumatic diseases. Arthritis Rheum. 44 (2001) 2221
15. Kavanaugh A., Tomar R., Reveille J., Solomon D.H., and Homburger H.A. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch. Pathol. Lab. Med. 124 (2000) 71
16. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159
17. Moder K.G., Wener M.H., Weisman M.H., Ishimori M.L., Wallace D.J., Buckeridge D.L., and Homburger H.A. Measurement of antinuclear antibodies by multiplex immunoassay: a prospective, multicenter clinical evaluation. J. Rheumatol. 34 (2007) 978
18. Neogi T., Gladman D.D., Ibanez D., and Urowitz M. Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent. J. Rheumatol. 33 (2006) 1785
19. Respaldiza N., Wichmann I., Ocana C., Garcia-Hernandez F.J., Castillo M.J., Magarino M.I., Magarino R., Torres A., Sanchez-Roman J., and Nunez-Roldan A. Anti-centromere antibodies in patients with systemic lupus erythematosus. Scand. J. Rheumatol. 35 (2006) 290
20. Prestigiacomo T., H.R., Larida B., and Binder S.R. Multiplexed analysis of thirteen antibodies using the BioPlex 2200 fully automated immunoassay analyzer. Autoantigens, autoantibodies. In: Conrad K. (Ed). In: S.U. (Ed). Autoantigens, Autoantibodies, Autoimmunity vol. 4 (2004) 463 Lengerich
21. Prestigiacomo T., H.R., Larida B., and Binder S.R. Multiplexed analysis of thirteen antibodies using the BioPlex 2200 fully automated immunoassay analyzer. Autoantigens, autoantibodies. In: S.U.C.K. (Ed). Autoantigens, Autoantibodies, Autoimmunity vol. 4 (2004) 463 Lengerich
22. Shovman O., Gilburd B., Barzilai O., Shinar E., Larida B., Zandman-Goddard G., Binder S.R., and Shoenfeld Y. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann. N. Y. Acad. Sci. 1050 (2005) 380
23. Stojanov L., Satoh M., Dooley M.A., Kuwana M., Jennette J.C., and Reeves W.H. Autoantibodies to topoisomerase I in a patient with systemic lupus erythematosus without features of scleroderma. Lupus 4 (1995) 314
24. Whitehouse I.J., Fehr K., and Wagenhauser F.J. Systemic lupus erythematosus and the crithidia luciliae immunofluorescent test. A comparative study with an adapted Farr radioimmunoassay. Z. Rheumatol. 42 (1983) 28
25. Wiik A.S., Gordon T.P., Kavanaugh A.F., Lahita R.G., Reeves W., van Venrooij W.J., Wilson M.R., and Fritzler M. Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Rheum. 51 (2004) 291